Client Onboarding & Implementation Tracker

Median Time-to-Value
24.3 days
-3.7 days vs. prior month
Active Implementations
18
Current pipeline
At-Risk Implementations
5
Trending up
Avg Health Score
68.2
-4.1 vs. prior month
Backlog in Queue
7
+3 vs. prior month
Onboarding NPS
+42
-8 vs. prior month

Active Implementation Timeline

Implementation Health Score Decomposition

Milestone Velocity Index by Stage

Implementation Status Detail

Account Name Segment ARR Lead Phase Health Days in Phase Stakeholder Eng. Integration Training Planned Go-Live
Vertex Biopharma Enterprise $1.4M Dr. E. Nakamura Build 38 23 days
4/7
Feb 14
Precision Health Sciences SMB $85K Maria Santos Training 55 11 days
3/3
Jan 28
Novagen Therapeutics Enterprise $890K James O'Brien UAT 71 6 days
5/5
Feb 8
ClearPath Biotech Mid-Market $220K Raj Patel Go-Live 92 2 days
4/4
Jan 22
BioPharma Solutions Enterprise $1.1M Dr. E. Nakamura Build 76 14 days
6/8
Feb 20
Genesis Clinical Labs Mid-Market $315K Lisa Andersen Kickoff 84 3 days
1/4
Mar 5
Apex Therapeutics Enterprise $950K James O'Brien Build 68 18 days
5/7
Feb 18
Meridian Research SMB $92K Thomas Wright Training 79 7 days
3/3
Feb 1

Onboarding NPS Trajectory by Touchpoint

Training Completion by Role

Backlog Aging Distribution

Go-Live Readiness Score

Team Utilization

Post-Go-Live Adoption Velocity (Last 6 Cohorts)

TTV vs. First-Year Retention Correlation

Implementation Risk Alerts

Vertex Biopharma
Integration Stall 23 days in Build
Dr. E. Nakamura
Precision Health Sciences
Training Gap 22% completion
Maria Santos
Novagen Therapeutics
Stakeholder Dropout 45% engagement
James O'Brien
Apex Therapeutics
Timeline Breach 18 days in Build
James O'Brien
BioGenesis Corp
Integration Stall 8 days delay
Lisa Andersen